Joeky Senders

41 Thirty-day outcomes after craniotomy References 1. Ostrom QT GH, Xu J, Kromer C, Wolinski Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diganosed int he United States in 2009-2013. Neuro-oncology. 2016;18:v1-v75. 2. Stupp R HM, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. Journal of Clinical Oncology. 2007;25(26):4127-4136. 3. Krivosheya D PS, Weinberg JS, Sawaya R. Technical principles in glioma surgery and preoperative considerations. Journal of Neuro-oncology. 2016;130(2):243-252. 4. Alan N, Seicean A, Seicean S, Neuhauser D, Benzel EC, Weil RJ. Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor. J Clin Neurosci. 2015;22(9):1413-1419. 5. Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. Journal of neurosurgery. 2003;98(6):1175-1181. 6. Dasenbrock HH, Devine CA, Liu KX, et al. Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis. Cancer. 2016. 7. Dasenbrock HH, Liu KX, Chavakula V, et al. Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Programanalysis. Journal of neurosurgery. 2017;126(3):677-689. 8. Dasenbrock HH, Liu KX, Devine CA, et al. Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurgical focus. 2015;39(6):E12. 9. Lassen B, Helseth E, Ronning P, et al. Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors. Neurosurgery. 2011;68(5):1259- 1268; discussion 1268-1259. 10. Marcus LP, McCutcheon BA, Noorbakhsh A, et al. Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). Journal of neurosurgery. 2014;120(5):1201-1211. 11. Missios S KP, Nanda A, Bekelis K. Craniotomy for glioma resection: a predictivemodel. World neurosurgery. 2015;83(6):957-964. 12. Nuno M, Mukherjee D, Carico C, et al. The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001-2007. Acta Neurochir (Wien). 2012;154(8):1343-1350. 13. Seicean A, Seicean S, Schiltz NK, et al. Short-term outcomes of craniotomy for malignant brain tumors in the elderly. Cancer. 2013;119(5):1058-1064. 14. Trinh VT, Davies JM, Berger MS. Surgery for primary supratentorial brain tumors in the United States, 2000-2009: effect of provider and hospital caseload on complication rates. Journal of neurosurgery. 2015;122(2):280-296. 15. Chang SM PI, McDermott M, Barker II FG, Schmidt MH, Huang W, Laws Jr ER, Lillehel KO, Bernstein M, Brem H, Sloan AE, Berger M, Glioma Outcomes Investigators. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. Journal of neurosurgery. 2003;98(6):1175-1181. 16. ACS NSQIP Hospitals. 2017; https://www.facs.org/search/nsqip-participants?allresults=. Accessed Oktober 9, 2017.